---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-033942"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2026-07-20T21:20:17+00:00"
generated_at: "2026-07-20T21:22:03.909327+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma clarifies warrant terms after two reverse splits; exercise price now $13,800

## Summary
- Original exercise price of $11.50 per share adjusted to $13,800 after 1-for-30 and 40-1 reverse splits.
- Warrant ratio changed to 1,200 warrants to purchase one share of common stock.
- Reverse splits effective January 16, 2026 and May 11, 2026.
- Clarification provided in response to requests from public warrant holders.
- Warrants trade under symbol ASBPW on Nasdaq.

## SEC filing metadata
- accession: 0001493152-26-033942
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2026-07-20T21:20:17+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315226033942/0001493152-26-033942-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315226033942/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-033942
- JSON: https://secwatch.observer/filing/0001493152-26-033942.json
- Plain text: https://secwatch.observer/filing/0001493152-26-033942.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.